Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by Pandoraon Sep 09, 2024 8:48pm

297 Views

Post# 36215826

Patent Status

16/608,558 | T1081/20075:

METHOD AND APPARATUS FOR PHOTOACTIVATING NUCLEAR RECEPTORS

This patent application was given an 'extension of time' status back in June. after a non-final rejection.
An examiner has once again reviewed it and on 2024/09/06 it was given a "Final Rejection" status. That suggests the Company will have to review the examiners reasons (usually within 90 days) and then decide if they wish to revise and return for review. In the meantime it is on the shelf.

<< Previous

Bullboard Posts

Next >>

Ur-Energy revises uranium production guidance for 2024